RNAi Therapeutics Market Growth, Innovations, and Market Size Forecast 2035
Market insights predict the global RNAi therapeutics industry will increase from USD $1.69 billion in 2026 to USD $5.90 billion by 2035, achieving a CAGR of 14.9%. In 2023, siRNA therapy dominated with a 64% market share, leading the RNA-based treatment space. Cancer remained the top focus, with oncology applications expected to stay ahead in the coming years. North America led the market, holding a 41% share, highlighting strong regional adoption and investment.
Last Updated : 06 July 2026Category: BiotechnologyInsight Code: 5115Format: PDF / PPT / Excel
Regulatory Framework for Leading Countries/Regions
Supply Demand Analysis
Production & Consumption Statistics
Export Import Statistics
Price Trend Analysis
Global RNAi Therapeutics Market Assessment
Overview
Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
siRNA
miRNA
Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Oncology
Cardiovascular Disease
Infectious Disease
Diabetes
Neurology
Other Applications
Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
North America RNAi Therapeutics Market Assessment
Overview
North America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
siRNA
miRNA
North America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Oncology
Cardiovascular Disease
Infectious Disease
Diabetes
Neurology
Other Applications
North America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Europe RNAi Therapeutics Market Assessment
Overview
Europe RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
siRNA
miRNA
Europe RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Oncology
Cardiovascular Disease
Infectious Disease
Diabetes
Neurology
Other Applications
Europe RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Asia Pacific RNAi Therapeutics Market Assessment
Overview
Asia Pacific RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
siRNA
miRNA
Asia Pacific RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Oncology
Cardiovascular Disease
Infectious Disease
Diabetes
Neurology
Other Applications
Asia Pacific RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Latin America RNAi Therapeutics Market Assessment
Overview
Latin America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
siRNA
miRNA
Latin America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Oncology
Cardiovascular Disease
Infectious Disease
Diabetes
Neurology
Other Applications
Latin America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Middle East and Africa RNAi Therapeutics Market Assessment
Overview
Middle East and Africa RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
siRNA
miRNA
Middle East and Africa RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Oncology
Cardiovascular Disease
Infectious Disease
Diabetes
Neurology
Other Applications
Middle East and Africa RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Company Profiles
Alnylam Pharmaceuticals, Inc.
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Novartis
Arbutus Biopharma
Arrowhead Pharmaceuticals
Novo Nordisk (Dicerna Pharmaceuticals)
Sirnaomics
Conclusion & Recommendations
FAQ's
Answer : The global RNAi therapeutics market is projected to grow from USD $1.69 billion in 2026 to approximately USD $5.90 billion by 2035, registering a CAGR of 14.90%.
Answer : North America leads the RNAi therapeutics market, with a significant presence of biopharmaceutical companies, robust research infrastructure, and supportive regulatory frameworks driving innovation and commercialization efforts.
Answer : National Institute of Health, World Health Organization, Food and Drug Administration, American Cancer Society.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
+1 804-441-9344
Download Sample
USA : +1 8044 419344
